Role of chaperone-mediated autophagy dysfunctions in the pathogenesis of Parkinson’s disease

Frontiers in Molecular Neuroscience

Volumn 9, Issue DEC2016, 2016, Pages

  Sala, Gessica ^a   Marinig, Daniele ^a   Arosio, Alessandro ^a   Ferrarese, Carlo ^a,b  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

Author keywords

Alpha synuclein; Chaperone mediated autophagy; Hsc70; Lamp2A; MEF2D; Parkinson s disease

Indexed keywords

CHAPERONE; GLUCOSYLCERAMIDASE; LEUCINE RICH REPEAT KINASE 2; OXIDOPAMINE;

ARTICLE; CHAPERONE-MEDIATED AUTOPHAGY; DOPAMINERGIC NERVE CELL; DOWN REGULATION; GENE MUTATION; HOMEOSTASIS; HUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PHOSPHORYLATION; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; TDP 43 PROTEINOPATHY; UPREGULATION;

EID: 85007480782     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2016.00157     Document Type: Article

References (70)

1. Agarraberes, F. A., and Dice, J. F. (2001). A molecular chaperone complex at the lysosomal membrane is required for protein translocation. J. Cell Sci. 114, 2491-2499.
2. Alvarez-Erviti, L., Rodriguez-Oroz, M. C., Cooper, J. M., Caballero, C., Ferrer, I., Obeso, J. A., et al. (2010). Chaperone-mediated autophagy markers in Parkinson disease brains. Arch. Neurol. 67, 1464-1472. doi: 10.1001/archneurol.2010.198
3. Alvarez-Erviti, L., Seow, Y., Schapira, A. H., Rodriguez-Oroz, M. C., Obeso, J. A., and Cooper, J. M. (2013). Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson’s disease. Cell Death Dis. 4:e545. doi: 10.1038/cddis.2013.73
4. Anderson, J. P., Walker, D. E., Goldstein, J. M., de Laat, R., Banducci, K., Caccavello, R. J., et al. (2006). Phosphorylation of Ser-129 is the dominant pathological modification of α-synuclein in familial and sporadic Lewy body disease. J. Biol. Chem. 281, 29739-29752. doi: 10.1074/jbc.m600933200
5. Anglade, P., Vyas, S., Javoy-Agid, F., Herrero, M. T., Michel, P. P., Marquez, J., et al. (1997). Apoptosis and autophagy in nigral neurons of patients with Parkinson’s disease. Histol. Histopathol. 12, 25-31.
6. Anguiano, J., Garner, T. P., Mahalingam, M., Das, B. C., Gavathiotis, E., and Cuervo, A. M. (2013). Chemical modulation of chaperone-mediated autophagy by retinoic acid derivatives. Nat. Chem. Biol. 9, 374-382. doi: 10.1038/nchembio.1230
7. Bandopadhyay, R., and de Belleroche, J. (2010). Pathogenesis of Parkinson’s disease: emerging role of molecular chaperones. Trends Mol. Med. 16, 27-36. doi: 10.1016/j.molmed.2009.11.004
8. Bandyopadhyay, U., Kaushik, S., Varticovski, L., and Cuervo, A. M. (2008). The chaperone-mediated autophagy receptor organizes in dynamic protein complexes at the lysosomal membrane. Mol. Cell. Biol. 28, 5747-5763. doi: 10.1128/mcb.02070-07
9. Chartier-Harlin, M. C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., et al. (2004). α-synuclein locus duplication as a cause of familial Parkinson’s disease. Lancet 364, 1167-1169. doi: 10.1016/S0140-6736(04)17103-1
10. Chiang, H. L., Terlecky, S. R., Plant, C. P., and Dice, J. F. (1989). A role for a 70-kilodalton heat shock protein in lysosomal degradation of intracellular proteins. Science 246, 382-385. doi: 10.1126/science.2799391
11. Chu, Y., Mickiewicz, A. L., and Kordower, J. H. (2011). α-synuclein aggregation reduces nigral myocyte enhancer factor-2D in idiopathic and experimental Parkinson’s disease. Neurobiol. Dis. 41, 71-82. doi: 10.1016/j.nbd.2010.08.022
12. Cuervo, A. M., and Dice, J. F. (1996). A receptor for the selective uptake and degradation of proteins by lysosomes. Science 273, 501-503. doi: 10.1126/science.273.5274.501
13. Cuervo, A. M., Hildebrand, H., Bomhard, E. M., and Dice, J. F. (1999). Direct lysosomal uptake of α 2-microglobulin contributes to chemically induced nephropathy. Kidney Int. 55, 529-545. doi: 10.1046/j.1523-1755.1999.00268.x
14. Cuervo, A. M., Knecht, E., Terlecky, S. R., and Dice, J. F. (1995a). Activation of a selective pathway of lysosomal proteolysis in rat liver by prolonged starvation. Am. J. Physiol. 269, C1200-C1208.
15. Cuervo, A. M., Palmer, A., Rivett, A. J., and Knecht, E. (1995b). Degradation of proteasomes by lysosomes in rat liver. Eur. J. Biochem. 227, 792-800. doi: 10.1111/j.1432-1033.1995.0792p.x
16. Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., and Sulzer, D. (2004). Impaired degradation of mutant α-synuclein by chaperone-mediated autophagy. Science 305, 1292-1295. doi: 10.1126/science.1101738
17. Dewaele, M., Martinet, W., Rubio, N., Verfaillie, T., de Witte, P. A., Piette, J., et al. (2011). Autophagy pathways activated in response to PDT contribute to cell resistance against ROS damage. J. Cell. Mol. Med. 15, 1402-1414. doi: 10.1111/j.1582-4934.2010.01118.x
18. Dice, J. F. (1990). Peptide sequences that target cytosolic proteins for lysosomal proteolysis. Trends Biochem. Sci. 15, 305-309. doi: 10.1016/0968-0004(90)90019-8
19. Ding, W. X., Ni, H. M., Gao, W., Yoshimori, T., Stolz, D. B., Ron, D., et al. (2007). Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability. Am. J. Pathol. 171, 513-524. doi: 10.2353/ajpath.2007.070188
20. Ebrahimi-Fakhari, D., Cantuti-Castelvetri, I., Fan, Z., Rockenstein, E., Masliah, E., Hyman, B. T., et al. (2011). Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of α-synuclein. J. Neurosci. 31, 14508-14520. doi: 10.1523/JNEUROSCI.1560-11.2011
21. Eskelinen, E. L., Schmidt, C. K., Neu, S., Willenborg, M., Fuertes, G., Salvador, N., et al. (2004). Disturbed cholesterol traffic but normal proteolytic function in LAMP-1/LAMP-2 double-deficient fibroblasts. Mol. Biol. Cell 15, 3132-3145. doi: 10.1091/mbc.e04-02-0103
22. Finn, P. F., Mesires, N. T., Vine, M., and Dice, J. F. (2005). Effects of small molecules on chaperone-mediated autophagy. Autophagy 1, 141-145. doi: 10.4161/auto.1.3.2000
23. Foulds, P. G., Mitchell, J. D., Parker, A., Turner, R., Green, G., Diggle, P., et al. (2011). Phosphorylated α-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson’s disease. FASEB J. 25, 4127-4137. doi: 10.1096/fj.10-179192
24. Fujiwara, H., Hasegawa, M., Dohmae, N., Kawashima, A., Masliah, E., Goldberg, M. S., et al. (2002). α-Synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell Biol. 4, 160-164. doi: 10.1038/ncb748
25. Gao, L., She, H., Li, W., Zeng, J., Zhu, J., Jones, D. P., et al. (2014). Oxidation of survival factor MEF2D in neuronal death and Parkinson’s disease. Antioxid. Redox Signal. 20, 2936-2948. doi: 10.1089/ars.2013.5399
26. Kabuta, T., Furuta, A., Aoki, S., Furuta, K., and Wada, K. (2008). Aberrant interaction between Parkinson disease-associated mutant UCH-L1 and the lysosomal receptor for chaperone-mediated autophagy. J. Biol. Chem. 283, 23731-23738. doi: 10.1074/jbc.M801918200
27. Kaushik, S., Massey, A. C., Mizushima, N., and Cuervo, A. M. (2008). Constitutive activation of chaperone-mediated autophagy in cells with impaired macroautophagy. Mol. Biol. Cell 19, 2179-2192. doi: 10.1091/mbc.E07-11-1155
28. Kiffin, R., Christian, C., Knecht, E., and Cuervo, A. M. (2004). Activation of chaperone-mediated autophagy during oxidative stress. Mol. Biol. Cell 15, 4829-4840. doi: 10.1091/mbc.e04-06-0477
29. Korolchuk, V. I., Mansilla, A., Menzies, F. M., and Rubinsztein, D. C. (2009). Autophagy inhibition compromises degradation of ubiquitin-proteasome pathway substrates. Mol. Cell 33, 517-527. doi: 10.1016/j.molcel.2009.01.021
30. Li, G., Yang, H., Zhu, D., Huang, H., Liu, G., and Lun, P. (2014). Targeted suppression of chaperone-mediated autophagy by miR-320a promotes α-synuclein aggregation. Int. J. Mol. Sci. 15, 15845-15857. doi: 10.3390/ijms150915845
31. Mak, S. K., McCormack, A. L., Manning-Bog, A. B., Cuervo, A. M., and Di Monte, D. A. (2010). Lysosomal degradation of alpha-synuclein in vivo. J Biol Chem 285, 13621-13629. doi: 10.1074/jbc.M109.074617
32. Marin, C., and Aguilar, E. (2011). In vivo 6-OHDA-induced neurodegeneration and nigral autophagic markers expression. Neurochem. Int. 58, 521-526. doi: 10.1016/j.neuint.2011.01.010
33. Martinez-Vicente, M., Talloczy, Z., Kaushik, S., Massey, A. C., Mazzulli, J., Mosharov, E. V., et al. (2008). Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy. J. Clin. Invest. 118, 777-788. doi: 10.1172/JCI32806
34. Massey, A. C., Kaushik, S., Sovak, G., Kiffin, R., and Cuervo, A. M. (2006). Consequences of the selective blockage of chaperone-mediated autophagy. Proc. Natl. Acad. Sci. U S A 103, 5805-5810. doi: 10.1073/pnas.0507436103
35. Mazzulli, J. R., Xu, Y. H., Sun, Y., Knight, A. L., McLean, P. J., Caldwell, G. A., et al. (2011). Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell 146, 37-52. doi: 10.1016/j.cell.2011.06.001
36. McNaught, K. S., and Olanow, C. W. (2003). Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson’s disease. Ann. Neurol. 53, S73-S84; discussion S84-S86. doi: 10.1002/ana.10512
37. Migdalska-Richards, A., and Schapira, A. H. (2016). The relationship between glucocerebrosidase mutations and Parkinson disease. J. Neurochem. 139, 77-90. doi: 10.1111/jnc.13385
38. Murphy, K. E., Gysbers, A. M., Abbott, S. K., Spiro, A. S., Furuta, A., Cooper, A., et al. (2015). Lysosomal-associated membrane protein 2 isoforms are differentially affected in early Parkinson’s disease. Mov. Disord. 30, 1639-1647. doi: 10.1002/mds.26141
39. Orenstein, S. J., Kuo, S. H., Tasset, I., Arias, E., Koga, H., Fernandez-Carasa, I., et al. (2013). Interplay of LRRK2 with chaperone-mediated autophagy. Nat. Neurosci. 16, 394-406. doi: 10.1038/nn.3350
40. Pandey, U. B., Nie, Z., Batlevi, Y., McCray, B. A., Ritson, G. P., Nedelsky, N. B., et al. (2007). HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 447, 859-863. doi: 10.1038/nature05853
41. Pang, S., Chen, D., Zhang, A., Qin, X., and Yan, B. (2012). Genetic analysis of the LAMP-2 gene promoter in patients with sporadic Parkinson’s disease. Neurosci. Lett. 526, 63-67. doi: 10.1016/j.neulet.2012.07.044
42. Papagiannakis, N., Xilouri, M., Koros, C., Stamelou, M., Antonelou, R., Maniati, M., et al. (2015). Lysosomal alterations in peripheral blood mononuclear cells of Parkinson’s disease patients. Mov. Disord. 30, 1830-1834. doi: 10.1002/mds.26433
43. Pemberton, S., Madiona, K., Pieri, L., Kabani, M., Bousset, L., and Melki, R. (2011). Hsc70 protein interaction with soluble and fibrillar α-synuclein. J. Biol. Chem. 286, 34690-34699. doi: 10.1074/jbc.M111.261321
44. Pemberton, S., and Melki, R. (2012). The interaction of Hsc70 protein with fibrillar α-Synuclein and its therapeutic potential in Parkinson’s disease. Commun. Integr. Biol. 5, 94-95. doi: 10.4161/cib.18483
45. Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., et al. (1997). Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science 276, 2045-2047. doi: 10.1126/science.276.5321.2045
46. Prigione, A., Piazza, F., Brighina, L., Begni, B., Galbussera, A., Difrancesco, J. C., et al. (2010). Alpha-synuclein nitration and autophagy response are induced in peripheral blood cells from patients with Parkinson disease. Neurosci. Lett. 477, 6-10. doi: 10.1016/j.neulet.2010.04.022
47. Qiao, L., and Zhang, J. (2009). Inhibition of lysosomal functions reduces proteasomal activity. Neurosci. Lett. 456, 15-19. doi: 10.1016/j.neulet.2009.03.085
48. Rothaug, M., Stroobants, S., Schweizer, M., Peters, J., Zunke, F., Allerding, M., et al. (2015). LAMP-2 deficiency leads to hippocampal dysfunction but normal clearance of neuronal substrates of chaperone-mediated autophagy in a mouse model for Danon disease. Acta Neuropathol. Commun. 3:6. doi: 10.1186/s40478-014-0182-y
49. Sala, G., Arosio, A., Stefanoni, G., Melchionda, L., Riva, C., Marinig, D., et al. (2013). Rotenone upregulates alpha-synuclein and myocyte enhancer factor 2D independently from lysosomal degradation inhibition. Biomed Res. Int. 2013:846725. doi: 10.1155/2013/846725
50. Sala, G., Marinig, D., Riva, C., Arosio, A., Stefanoni, G., Brighina, L., et al. (2016). Rotenone down-regulates HSPA8/hsc70 chaperone protein in vitro: a new possible toxic mechanism contributing to Parkinson’s disease. Neurotoxicology 54, 161-169. doi: 10.1016/j.neuro.2016.04.018
51. Sala, G., Stefanoni, G., Arosio, A., Riva, C., Melchionda, L., Saracchi, E., et al. (2014). Reduced expression of the chaperone-mediated autophagy carrier hsc70 protein in lymphomonocytes of patients with Parkinson’s disease. Brain Res. 1546, 46-52. doi: 10.1016/j.brainres.2013.12.017
52. She, H., Yang, Q., Shepherd, K., Smith, Y., Miller, G., Testa, C., et al. (2011). Direct regulation of complex I by mitochondrial MEF2D is disrupted in a mouse model of Parkinson disease and in human patients. J. Clin. Invest. 121, 930-940. doi: 10.1172/JCI43871
53. Sidransky, E., and Lopez, G. (2012). The link between the GBA gene and parkinsonism. Lancet Neurol. 11, 986-998. doi: 10.1016/S1474-4422(12)70190-4
54. Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., et al. (2003). α-Synuclein locus triplication causes Parkinson’s disease. Science 302:841. doi: 10.1126/science.1090278
55. Sooparb, S., Price, S. R., Shaoguang, J., and Franch, H. A. (2004). Suppression of chaperone-mediated autophagy in the renal cortex during acute diabetes mellitus. Kidney Int. 65, 2135-2144. doi: 10.1111/j.1523-1755.2004.00639.x
56. Spillantini, M. G., Schmidt, M. L., Lee, V. M., Trojanowski, J. Q., Jakes, R., and Goedert, M. (1997). Alpha-synuclein in Lewy bodies. Nature 388, 839-840. doi: 10.1038/42166
57. Su, C., Yang, X., and Lou, J. (2016). Geniposide reduces α-synuclein by blocking microRNA-21/lysosome-associated membrane protein 2A interaction in Parkinson disease models. Brain Res. 1644, 98-106. doi: 10.1016/j.brainres.2016.05.011
58. Vogiatzi, T., Xilouri, M., Vekrellis, K., and Stefanis, L. (2008). Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells. J. Biol. Chem. 283, 23542-23556. doi: 10.1074/jbc.M801992200
59. Wang, B., Cai, Z., Lu, F., Li, C., Zhu, X., Su, L., et al. (2014). Destabilization of survival factor MEF2D mRNA by neurotoxin in models of Parkinson’s disease. J. Neurochem. 130, 720-728. doi: 10.1111/jnc.12765
60. Wang, B., Cai, Z., Tao, K., Zeng, W., Lu, F., Yang, R., et al. (2016). Essential control of mitochondrial morphology and function by chaperone-mediated autophagy through degradation of PARK7. Autophagy 12, 1215-1228. doi: 10.1080/15548627.2016.1179401
61. Wang, Y., Singh, R., Massey, A. C., Kane, S. S., Kaushik, S., Grant, T., et al. (2008). Loss of macroautophagy promotes or prevents fibroblast apoptosis depending on the death stimulus. J. Biol. Chem. 283, 4766-4777. doi: 10.1074/jbc.M706666200
62. Wu, G., Wang, X., Feng, X., Zhang, A., Li, J., Gu, K., et al. (2011). Altered expression of autophagic genes in the peripheral leukocytes of patients with sporadic Parkinson’s disease. Brain Res. 1394, 105-111. doi: 10.1016/j.brainres.2011.04.013
63. Xilouri, M., Brekk, O. R., Polissidis, A., Chrysanthou-Piterou, M., Kloukina, I., and Stefanis, L. (2016). Impairment of chaperone-mediated autophagy induces dopaminergic neurodegeneration in rats. Autophagy 12, 2230-2247. doi: 10.1080/15548627.2016.1214777
64. Xilouri, M., Brekk, O. R., Landeck, N., Pitychoutis, P. M., Papasilekas, T., Papadopoulou-Daifoti, Z., et al. (2013a). Boosting chaperone-mediated autophagy in vivo mitigates α-synuclein-induced neurodegeneration. Brain 136, 2130-2146. doi: 10.1093/brain/awt131
65. Xilouri, M., Brekk, O. R., and Stefanis, L. (2013b). α-Synuclein and protein degradation systems. a reciprocal relationship. Mol. Neurobiol. 47, 537-551. doi: 10.1007/s12035-012-8341-2
66. Xilouri, M., Vogiatzi, T., Vekrellis, K., Park, D., and Stefanis, L. (2009). Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy. PLoS One 4:e5515. doi: 10.1371/journal.pone.0005515
67. Yang, Q., She, H., Gearing, M., Colla, E., Lee, M., Shacka, J. J., et al. (2009). Regulation of neuronal survival factor MEF2D by chaperone-mediated autophagy. Science 323, 124-127. doi: 10.1126/science.1166088
68. Yao, L., Li, W., She, H., Dou, J., Jia, L., He, Y., et al. (2012). Activation of transcription factor MEF2D by bis(3)-cognitin protects dopaminergic neurons and ameliorates Parkinsonian motor defects. J. Biol. Chem. 287, 34246-34255. doi: 10.1074/jbc.M112.367540
69. Zhang, C., and Cuervo, A. M. (2008). Restoration of chaperone-mediated autophagy in aging liver improves cellular maintenance and hepatic function. Nat. Med. 14, 959-965. doi: 10.1038/nm.1851
70. Zhou, D., Li, P., Lin, Y., Lott, J. M., Hislop, A. D., Canaday, D. H., et al. (2005). Lamp-2a facilitates MHC class II presentation of cytoplasmic antigens. Immunity 22, 571-581. doi: 10.1016/j.immuni.2005.03.009